세계의 측방유동 어세이 시장 : 제품, 기술, 검사 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Lateral Flow Assays Market was valued at USD 9.65 billion in 2023, expected to reach USD 10.03 billion in 2024, and is projected to grow at a CAGR of 4.30%, to USD 12.96 billion by 2030.

Lateral flow assays (LFAs) are diagnostic devices employed in point-of-care testing for the detection of specific antigens or antibodies in samples. The necessity of LFAs is underscored by their ability to provide rapid, simple, cost-effective, and accurate testing without the need for specialized equipment, making them indispensable in healthcare, agriculture, food safety, and environmental testing. Their primary applications include infectious disease detection, pregnancy testing, and monitoring of health and safety in various fields. The end-use scope extends across hospitals, diagnostic laboratories, home care settings, and research institutions. Key growth factors influencing the market include increased demand for point-of-care testing, the prevalence of infectious diseases, and technological advancements increasing assay sensitivity and specificity. The COVID-19 pandemic has further accelerated demand, underscoring the importance of fast, reliable testing methods.

The market faces challenges such as regulatory hurdles, variability in test sensitivity and specificity, and limited detection scope for certain assays when compared to laboratory-based diagnostics. Additionally, market growth is constrained by competition from alternative diagnostic tools like PCR-based tests. However, potential opportunities lie in expanding LFAs into emerging markets and developing multi-analyte detection capabilities and digital integration for better data management.

Innovation in this space could focus on the development of more sensitive and specific tests, integration with digital health tools, and expansion into novel applications like veterinary diagnostics and bioterrorism agent detection. Research should also explore improving sample preparation methods and minimizing cross-reactivity. The nature of the LFA market is highly competitive, characterized by a few major players investing in product development and geographical expansion. For businesses looking to grow, strategic collaboration with healthcare providers, investment in R&D for product enhancement, and targeting unmet needs in underserved regions will be crucial.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Lateral Flow Assays Market

The Lateral Flow Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of infectious diseases across the globe
  • Growing adoption of lateral flow assay devices in home care settings
  • Increasing demand for lateral flow assay from food & beverage industry for testing of food quality
• Market Restraints
  • Low accuracy and inconsistent results of lateral flow assay tests
• Market Opportunities
  • Technological advancements and increase in R&D activities associated with lateral flow assays
  • Emergence of point-of-care testing for rapid provision of test results
• Market Challenges
  • Concerns about image processing using mobile POC diagnostics

Porter's Five Forces: A Strategic Tool for Navigating the Lateral Flow Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Lateral Flow Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Lateral Flow Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Lateral Flow Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Lateral Flow Assays Market

A detailed market share analysis in the Lateral Flow Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Lateral Flow Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Lateral Flow Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Lateral Flow Assays Market

A strategic analysis of the Lateral Flow Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Lateral Flow Assays Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Inc., Abcam PLC, BBI Solutions, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., BioFluidix GmbH by Hamilton Company, BioMerieux SA, BioPorto Diagnostics A/S, BOC Sciences, Cytodiagnostics Inc., Danaher Corporation, Elabscience Biotechnology Inc., F. Hoffmann-La Roche AG, Fortis Life Sciences, Hologic, Inc., Leinco Technologies, Merck KGaA, Microcoat Biotechnologie GmbH, Milenia Biotec GmbH, PerkinElmer Inc., Porex Filtration Group, QIAGEN GmbH, Quidel Corporation, R-Biopharm AG, Rockland Immunochemicals, Inc., Shenzhen SEKBIO Co., Ltd., Siemens AG, Tetracore, Inc., Thermo Fisher Scientific, Inc., and VDO Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Lateral Flow Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Kits & Reagents and Lateral Flow Readers. The Lateral Flow Readers is further studied across Benchtop Readers, Digital or Handheld Readers, and Mobile or Smartphone Readers.
• Based on Technique, market is studied across Competitive Assays, Multiplex Detection Assays, and Sandwich Assays.
• Based on Test Type, market is studied across Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay.
• Based on Application, market is studied across Clinical Testing, Drug Development & Quality Testing, Food Safety & Environment Testing, and Veterinary Diagnostics.
• Based on End-User, market is studied across Diagnostic Laboratories, Home Care Settings, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of infectious diseases across the globe
    • 5.1.1.2. Growing adoption of lateral flow assay devices in home care settings
    • 5.1.1.3. Increasing demand for lateral flow assay from food & beverage industry for testing of food quality
  • 5.1.2. Restraints
    • 5.1.2.1. Low accuracy and inconsistent results of lateral flow assay tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements and increase in R&D activities associated with lateral flow assays
    • 5.1.3.2. Emergence of point-of-care testing for rapid provision of test results
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns about image processing using mobile POC diagnostics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Emerging advancements to improve the functionality, performance, and applicability of kits and reagents
  • 5.2.2. Application: Need for rapid, accurate, and accessible solutions in clinical testing
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Lateral Flow Assays Market, by Product

• 6.1. Introduction
• 6.2. Kits & Reagents
• 6.3. Lateral Flow Readers
  • 6.3.1. Benchtop Readers
  • 6.3.2. Digital or Handheld Readers
  • 6.3.3. Mobile or Smartphone Readers

7. Lateral Flow Assays Market, by Technique

• 7.1. Introduction
• 7.2. Competitive Assays
• 7.3. Multiplex Detection Assays
• 7.4. Sandwich Assays

8. Lateral Flow Assays Market, by Test Type

• 8.1. Introduction
• 8.2. Lateral Flow Immunoassay
• 8.3. Nucleic Acid Lateral Flow Assay

9. Lateral Flow Assays Market, by Application

• 9.1. Introduction
• 9.2. Clinical Testing
• 9.3. Drug Development & Quality Testing
• 9.4. Food Safety & Environment Testing
• 9.5. Veterinary Diagnostics

10. Lateral Flow Assays Market, by End-User

• 10.1. Introduction
• 10.2. Diagnostic Laboratories
• 10.3. Home Care Settings
• 10.4. Hospitals & Clinics
• 10.5. Pharmaceutical & Biotechnology Companies

11. Americas Lateral Flow Assays Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Lateral Flow Assays Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Lateral Flow Assays Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Neogen Launches New Assays for Histamine Detection
  • 14.3.2. MaximBio receives Contract from NIH to develop a new Rapid Test Platform
  • 14.3.3. Thermo Fisher Scientific Completes Acquisition of The Binding Site Group
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories, Inc.
• 2. Abcam PLC
• 3. BBI Solutions
• 4. Becton, Dickinson and Company
• 5. Bio-Rad Laboratories, Inc.
• 6. Bio-Techne Corp.
• 7. BioFluidix GmbH by Hamilton Company
• 8. BioMerieux SA
• 9. BioPorto Diagnostics A/S
• 10. BOC Sciences
• 11. Cytodiagnostics Inc.
• 12. Danaher Corporation
• 13. Elabscience Biotechnology Inc.
• 14. F. Hoffmann-La Roche AG
• 15. Fortis Life Sciences
• 16. Hologic, Inc.
• 17. Leinco Technologies
• 18. Merck KGaA
• 19. Microcoat Biotechnologie GmbH
• 20. Milenia Biotec GmbH
• 21. PerkinElmer Inc.
• 22. Porex Filtration Group
• 23. QIAGEN GmbH
• 24. Quidel Corporation
• 25. R-Biopharm AG
• 26. Rockland Immunochemicals, Inc.
• 27. Shenzhen SEKBIO Co., Ltd.
• 28. Siemens AG
• 29. Tetracore, Inc.
• 30. Thermo Fisher Scientific, Inc.
• 31. VDO Biotech Co., Ltd.